Cargando…

Evaluation of the Microbial Diversity in Amyotrophic Lateral Sclerosis Using High-Throughput Sequencing

More and more evidences indicate that diseases of the central nervous system have been seriously affected by fecal microbes. However, little work is done to explore interaction between amyotrophic lateral sclerosis (ALS) and fecal microbes. In the present study, high-throughput sequencing method was...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Xin, Wang, Xin, Yang, Shaoguo, Meng, Fanjing, Wang, Xiaolei, Wei, Hua, Chen, Tingtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028383/
https://www.ncbi.nlm.nih.gov/pubmed/27703453
http://dx.doi.org/10.3389/fmicb.2016.01479
_version_ 1782454359638933504
author Fang, Xin
Wang, Xin
Yang, Shaoguo
Meng, Fanjing
Wang, Xiaolei
Wei, Hua
Chen, Tingtao
author_facet Fang, Xin
Wang, Xin
Yang, Shaoguo
Meng, Fanjing
Wang, Xiaolei
Wei, Hua
Chen, Tingtao
author_sort Fang, Xin
collection PubMed
description More and more evidences indicate that diseases of the central nervous system have been seriously affected by fecal microbes. However, little work is done to explore interaction between amyotrophic lateral sclerosis (ALS) and fecal microbes. In the present study, high-throughput sequencing method was used to compare the intestinal microbial diversity of healthy people and ALS patients. The principal coordinate analysis, Venn and unweighted pair-group method using arithmetic averages (UPGMA) showed an obvious microbial changes between healthy people (group H) and ALS patients (group A), and the average ratios of Bacteroides, Faecalibacterium, Anaerostipes, Prevotella, Escherichia, and Lachnospira at genus level between ALS patients and healthy people were 0.78, 2.18, 3.41, 0.35, 0.79, and 13.07. Furthermore, the decreased Firmicutes/Bacteroidetes ratio at phylum level using LEfSE (LDA > 4.0), together with the significant increased genus Dorea (harmful microorganisms) and significant reduced genus Oscillibacter, Anaerostipes, Lachnospiraceae (beneficial microorganisms) in ALS patients, indicated that the imbalance in intestinal microflora constitution had a strong association with the pathogenesis of ALS.
format Online
Article
Text
id pubmed-5028383
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-50283832016-10-04 Evaluation of the Microbial Diversity in Amyotrophic Lateral Sclerosis Using High-Throughput Sequencing Fang, Xin Wang, Xin Yang, Shaoguo Meng, Fanjing Wang, Xiaolei Wei, Hua Chen, Tingtao Front Microbiol Microbiology More and more evidences indicate that diseases of the central nervous system have been seriously affected by fecal microbes. However, little work is done to explore interaction between amyotrophic lateral sclerosis (ALS) and fecal microbes. In the present study, high-throughput sequencing method was used to compare the intestinal microbial diversity of healthy people and ALS patients. The principal coordinate analysis, Venn and unweighted pair-group method using arithmetic averages (UPGMA) showed an obvious microbial changes between healthy people (group H) and ALS patients (group A), and the average ratios of Bacteroides, Faecalibacterium, Anaerostipes, Prevotella, Escherichia, and Lachnospira at genus level between ALS patients and healthy people were 0.78, 2.18, 3.41, 0.35, 0.79, and 13.07. Furthermore, the decreased Firmicutes/Bacteroidetes ratio at phylum level using LEfSE (LDA > 4.0), together with the significant increased genus Dorea (harmful microorganisms) and significant reduced genus Oscillibacter, Anaerostipes, Lachnospiraceae (beneficial microorganisms) in ALS patients, indicated that the imbalance in intestinal microflora constitution had a strong association with the pathogenesis of ALS. Frontiers Media S.A. 2016-09-20 /pmc/articles/PMC5028383/ /pubmed/27703453 http://dx.doi.org/10.3389/fmicb.2016.01479 Text en Copyright © 2016 Fang, Wang, Yang, Meng, Wang, Wei and Chen. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Fang, Xin
Wang, Xin
Yang, Shaoguo
Meng, Fanjing
Wang, Xiaolei
Wei, Hua
Chen, Tingtao
Evaluation of the Microbial Diversity in Amyotrophic Lateral Sclerosis Using High-Throughput Sequencing
title Evaluation of the Microbial Diversity in Amyotrophic Lateral Sclerosis Using High-Throughput Sequencing
title_full Evaluation of the Microbial Diversity in Amyotrophic Lateral Sclerosis Using High-Throughput Sequencing
title_fullStr Evaluation of the Microbial Diversity in Amyotrophic Lateral Sclerosis Using High-Throughput Sequencing
title_full_unstemmed Evaluation of the Microbial Diversity in Amyotrophic Lateral Sclerosis Using High-Throughput Sequencing
title_short Evaluation of the Microbial Diversity in Amyotrophic Lateral Sclerosis Using High-Throughput Sequencing
title_sort evaluation of the microbial diversity in amyotrophic lateral sclerosis using high-throughput sequencing
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028383/
https://www.ncbi.nlm.nih.gov/pubmed/27703453
http://dx.doi.org/10.3389/fmicb.2016.01479
work_keys_str_mv AT fangxin evaluationofthemicrobialdiversityinamyotrophiclateralsclerosisusinghighthroughputsequencing
AT wangxin evaluationofthemicrobialdiversityinamyotrophiclateralsclerosisusinghighthroughputsequencing
AT yangshaoguo evaluationofthemicrobialdiversityinamyotrophiclateralsclerosisusinghighthroughputsequencing
AT mengfanjing evaluationofthemicrobialdiversityinamyotrophiclateralsclerosisusinghighthroughputsequencing
AT wangxiaolei evaluationofthemicrobialdiversityinamyotrophiclateralsclerosisusinghighthroughputsequencing
AT weihua evaluationofthemicrobialdiversityinamyotrophiclateralsclerosisusinghighthroughputsequencing
AT chentingtao evaluationofthemicrobialdiversityinamyotrophiclateralsclerosisusinghighthroughputsequencing